Title | E-Cigarette-Related Nicotine Misinformation on Social Media. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Sidani, JE, Hoffman, BL, Colditz, JB, Melcher, E, Taneja, SBathla, Shensa, A, Primack, BA, Davis, E, Chu, K-H |
Journal | Subst Use Misuse |
Volume | 57 |
Issue | 4 |
Pagination | 588-594 |
Date Published | 01/2022 |
ISSN | 1532-2491 |
Keywords | Communication, Electronic Nicotine Delivery Systems, Humans, Nicotine, Social Media, Vaping |
Abstract | BackgroundTwitter provides an opportunity to examine misperceptions about nicotine and addiction as they pertain to electronic nicotine delivery systems (ENDS). The purpose of this study was to systematically examine a sample of ENDS-related tweets that presented information about nicotine or addiction for the presence of potential misinformation. MethodsA total of 10.1 million ENDS-related tweets were obtained from April 2018 through March 2019 and were filtered for unique tweets containing keywords for nicotine and addiction. A subsample (n = 3,116) were human coded for type of account (individual, group, commercial, or news) and presence of potential misinformation. ResultsOf tweets that presented ENDS-related nicotine or addiction information (n = 904), 41.7% (n = 377) contained potential misinformation coded as anti-vaping exaggeration, pro-vaping exaggeration, nicotine is not addictive or is never harmful, or unproven health benefits. ConclusionsAnti-vaping exaggeration tweets distorted or embellished claims about ENDS nicotine and addiction; pro-vaping exaggeration tweets misinterpreted results from scientific studies. Misinformation that nicotine is not addictive or is never harmful or has unproven health benefits appeared less but are potentially problematic. ENDS-related messaging should be designed to be easily understood by the public and monitored to detect the spread of misinterpretation or misinformation on social media. |
DOI | 10.1080/10826084.2022.2026963 |
Alternate Journal | Subst Use Misuse |
PubMed ID | 35068338 |
Grant List | R01 CA225773 / CA / NCI NIH HHS / United States K12 DA050607 / DA / NIDA NIH HHS / United States K07 CA222338 / CA / NCI NIH HHS / United States |